ADUS, US0067391062

Eleven analysts set a USD 129.33 target for Addus HomeCare stock

Published on 10/20/2026 at 21:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Second-quarter revenue rose 8.00 percent to USD 377.41 million. Addus HomeCare stock costs EUR 105.00 on October 20, 2026 at Lang & Schwarz.

Analyst target and earnings

  • MarketBeat reported an average USD 129.33 target from eleven analysts on October 13, 2026.
  • Addus HomeCare's second-quarter revenue rose 8.00 percent to USD 377.41 million.
  • Addus HomeCare stock costs EUR 105.00 at Lang & Schwarz on October 20, 2026 at 9:22 p.m. CEST.
  • The next results date is November 2, 2026.
ADUS, US0067391062, Illustration mit AI erstellt.

Addus HomeCare (ISIN US0067391062) has an average USD 129.33 price target from eleven analysts, according to MarketBeat on October 13, 2026. The average target was based on five buy ratings, one strong buy, four hold ratings and one sell rating. Addus HomeCare stock was trading at EUR 105.00 at Lang & Schwarz on October 20, 2026 at 9:22 p.m. CEST.

Revenue growth remains the key figure

Addus HomeCare reported second-quarter revenue of USD 377.41 million on August 3, 2026, up 8.00 percent from the prior-year quarter. Adjusted earnings per share reached USD 1.73, compared with a USD 1.70 consensus estimate, according to MarketBeat. The company lists the second-quarter results announcement on August 3, 2026 on its Addus HomeCare investor page.

Nasdaq valuation and price position

On the Nasdaq, ADUS was trading at USD 117.48 on October 20, 2026 at 3:30 p.m. ET. The USD 129.33 consensus target therefore stood 10.09 percent above that Nasdaq price. The same quote showed a 52-week range of USD 87.95 to USD 124.44, placing the stock 5.60 percent below its high.

What date comes next?

Addus HomeCare is scheduled to report September 2026 results on November 2, 2026, according to MetaCap. That date gives the revenue trend and adjusted earnings comparison a near-term test, while the consensus target keeps the current valuation discussion tied to analyst expectations.

Services support the operating picture

Addus HomeCare operates personal care, home health and hospice services for older adults and people who need assistance at home. Personal care represented 78.40 percent of second-quarter revenue and grew organically 6.80 percent year over year, while hospice grew organically 11.10 percent, according to Yahoo Finance on September 23, 2026.

Stock and upcoming results

The next reported figure to watch is the September-quarter result on November 2, 2026. Addus HomeCare stock was trading at EUR 105.00 at Lang & Schwarz on October 20, 2026 at 9:22 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Addus HomeCare stock.

Addus HomeCare stock facts

  • Company: Addus HomeCare Corporation
  • ISIN: US0067391062
  • Ticker: ADUS
  • Primary exchange: Nasdaq
  • Price Lang & Schwarz as of October 20, 2026 at 9:22 p.m. CEST: EUR 105.00
  • Market capitalization: USD 2.2 billion (as of October 20, 2026)
  • 52-week range: USD 87.95-124.44 (as of October 20, 2026)
  • Sector / Industry: Health Care / Medical and Nursing Services
  • Next earnings date: November 2, 2026

Market context: Market report S&P 500.

More news and analyses on Addus HomeCare stock

Disclaimer...
en | US0067391062 | ADUS | boerse | 70378012 | bgmi